Drug Pipeline News Drug Pipeline List

Drug Pipeline News Drug Pipeline List

J&J: FDA Approves Doribax For Intra-Abdominal UTIs October, 2007

The Food and Drug Administration approved Doribax as a new treatment for complicated intra-abdominal and complicated urinary tract infections, including pyelonephritis.

Johnson & Johnson (JNJ) said Doribax demonstrated activity against a wide range of gram-positive and gram-negative bacteria -- including Pseudomonas -- that cause serious infections.

Doribax belongs to a class of antibacterial agents called carbapenems, which are important for treating serious infections caused by bacteria.

Drug Pipeline News archive:

Drug Pipeline Copyright © 2005- 2018 All Rights Reserved.